The IFNG-producing cells were the endpoint for the dasatinib-associated maturation trajectory (Figure 6D), indicating that in patients with PE/PAH, CD8+ T cell maturation did not end as expected. The gene discussed is CD8A; the disease is pulmonary arterial hypertension.